CDKAL1: A Promising Drug Target and Biomarker for Threonylcarbamoyladenosine tRNA Methylthiotransferase

Target Name: CDKAL1

NCBI ID: G54901

CDKAL1

Other Name(s): Threonylcarbamoyladenosine tRNA methylthiotransferase | tRNA-t(6)A37 methylthiotransferase | CDK5 regulatory subunit-associated protein 1-like 1 | CDKAL_HUMAN | CDK5 regulatory subunit associated protein 1 like 1

CDKAL1: A Promising Drug Target and Biomarker for Threonylcarbamoyladenosine tRNA Methylthiotransferase

Abstract:

CDKAL1 (Threonylcarbamoyladenosine tRNA methylthiotransferase) is a protein that plays a crucial role in the regulation of tRNA metabolism in eukaryotic cells. The deletion of the CDKAL1 gene has been associated with a range of physiological and therapeutic effects, including altered tRNA levels, impaired translation efficiency, and altered cellular metabolism. In this article, we will discuss the potential implications of CDKAL1 as a drug target and biomarker.

Introduction:

CDKAL1 is a member of the CDKAL family, which includes proteins involved in the regulation of amino acid metabolism, including tRNA metabolism. The CDKAL1 gene was identified as a potential drug target in the context of threonylcarbamoyladenosine (TCA), a metabolite that has been shown to play a role in a variety of cellular processes, including cellular signaling, DNA replication, and neurotransmission. TCA has also been linked to a range of diseases, including neurodegenerative disorders, cancer, and autoimmune diseases.

The Importance of CDKAL1 in TRNA Management:

CDKAL1 is involved in the regulation of tRNA levels, including tRNA processing, loading, and maturation. These processes are critical for the accurate translation of genetic information from the DNA to the protein synthesis machinery. CDKAL1 is known to play a role in the post-translational modification (PTM) of tRNA, specifically the addition of methyl groups to specific amino acids. This modification is critical for the stability and stability of tRNA, and is also involved in the regulation of tRNA levels and interactions with other cellular components.

The Role of CDKAL1 in TRNA Methylation:

CDKAL1 is involved in the regulation of tRNA methylation, a process that involves the addition of methyl groups to specific amino acids in tRNA. This modification is critical for the stability and stability of tRNA, and is also involved in the regulation of tRNA levels and interactions with other cellular components. CDKAL1 has been shown to play a role in the regulation of tRNA methylation by adding methyl groups to specific amino acids, including lysine and arginine.

The Potential Implications of CDKAL1 as a Drug Target:

The potential implications of CDKAL1 as a drug target are significant. The regulation of tRNA methylation by CDKAL1 is a potential target for the development of drugs that can modulate tRNA levels and improve protein synthesis. This is an attractive prospect given the involvement of tRNA methylation in a variety of cellular processes, including cellular signaling, DNA replication, and neurotransmission.

In addition, the regulation of tRNA methylation by CDKAL1 is also a potential target for the development of drugs that can modulate tRNA levels in neurodegenerative disorders. neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, are characterized by the progressive loss of brain cells and the disruption of normal cellular processes. The regulation of tRNA methylation by CDKAL1 is involved in the regulation of tRNA levels, which is potentially relevant to the pathology observed in neurodegenerative disorders.

The Potential Role of CDKAL1 as a Biomarker:

The regulation of tRNA methylation by CDKAL1 is also a potential biomarker for a variety of diseases. The deletion of the CDKAL1 gene has been associated with a range of physiological and therapeutic effects, including altered tRNA levels, impaired translation efficiency, and altered cellular metabolism. These effects are potentially relevant to the regulation of tRNA methylation and could be used as a

Protein Name: CDK5 Regulatory Subunit Associated Protein 1 Like 1

Functions: Catalyzes the methylthiolation of N6-threonylcarbamoyladenosine (t(6)A), leading to the formation of 2-methylthio-N6-threonylcarbamoyladenosine (ms(2)t(6)A) at position 37 in tRNAs that read codons beginning with adenine

The "CDKAL1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CDKAL1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets